Danaher Co. (NYSE:DHR) Shares Sold by Oak Ridge Investments LLC
Oak Ridge Investments LLC trimmed its position in shares of Danaher Co. (NYSE:DHR) by 8.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 77,718 shares of the conglomerate’s stock after selling 6,786 shares during the period. Danaher accounts for 1.1% of Oak Ridge Investments LLC’s investment portfolio, making the stock its 25th biggest holding. Oak Ridge Investments LLC’s holdings in Danaher were worth $10,757,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. JJJ Advisors Inc. bought a new stake in shares of Danaher during the 4th quarter valued at approximately $26,000. Archer Investment Corp acquired a new position in shares of Danaher in the 4th quarter worth approximately $27,000. Lion Street Advisors LLC acquired a new position in shares of Danaher during the 1st quarter valued at $25,000. Tobias Financial Advisors Inc. acquired a new position in shares of Danaher during the 4th quarter valued at $30,000. Finally, Liberty Wealth Management LLC lifted its position in shares of Danaher by 852.4% during the 4th quarter. Liberty Wealth Management LLC now owns 200 shares of the conglomerate’s stock valued at $31,000 after acquiring an additional 179 shares during the period. Hedge funds and other institutional investors own 77.80% of the company’s stock.
In other news, Director Walter G. Lohr sold 11,014 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $165.61, for a total value of $1,824,028.54. Following the sale, the director now directly owns 22,392 shares of the company’s stock, valued at $3,708,339.12. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Daniel Raskas sold 37,082 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $164.09, for a total transaction of $6,084,785.38. Following the completion of the sale, the senior vice president now directly owns 19,723 shares in the company, valued at $3,236,347.07. The disclosure for this sale can be found here. Over the last three months, insiders sold 85,318 shares of company stock worth $13,941,119. Insiders own 11.70% of the company’s stock.
NYSE DHR traded up $2.08 during trading on Wednesday, hitting $169.04. 213,827 shares of the company’s stock traded hands, compared to its average volume of 3,507,177. The stock has a market capitalization of $117.20 billion, a price-to-earnings ratio of 38.30, a PEG ratio of 3.73 and a beta of 0.91. Danaher Co. has a 12-month low of $119.60 and a 12-month high of $170.64. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.01 and a current ratio of 1.32. The business has a 50 day moving average of $160.40 and a 200-day moving average of $152.64.
Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, May 6th. The conglomerate reported $1.05 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.05. The business had revenue of $4.34 billion for the quarter, compared to the consensus estimate of $4.32 billion. Danaher had a net margin of 16.85% and a return on equity of 11.52%. The company’s revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.07 earnings per share. On average, analysts expect that Danaher Co. will post 4.88 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.43%. The ex-dividend date of this dividend is Thursday, June 25th. Danaher’s dividend payout ratio (DPR) is presently 16.29%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: Technical Analysis of Stocks, How Can It Help
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.